Drugs / ACTH
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02132195 Comparator | May 2014 → Jan 2018 | nephrotic syndrome | Emory University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02132195 ↗ |
| Route | Subcutaneous | “Patients will receive ACTH twice weekly subcutaneously” NCT02132195 ↗ |